Shareholders in InDex Pharmaceuticals Holding AB as of September 30, 2022.
| Shareholder | Number of Shares | Ownership, % | Votes, % |
|---|---|---|---|
| Linc AB | 69,920,567 | 13.1% | 13.1% |
| HBM Healthcare Investments | 52,916,667 | 9.9% | 9.9% |
| Fjärde AP-fonden | 52,314,074 | 9.8% | 9.8% |
| Handelsbanken Funds | 24,872,696 | 4.7% | 4.7% |
| SEB-Stiftelsen | 19,047,617 | 3.6% | 3.6% |
| Avanza Pension | 18,474,931 | 3.5% | 3.5% |
| SEB Life International | 13,927,350 | 2.6% | 2.6% |
| SEB Venture Capital | 12,993,367 | 2.4% | 2.4% |
| Stiftelsen Industrifonden | 12,865,296 | 2.4% | 2.4% |
| Nordnet Pensionsförsäkring | 11,356,534 | 2.1% | 2.1% |
| Swedbank försäkring AB | 10,366,743 | 2.0% | 2.0% |
| S-E-Bankens Utvecklingsstiftelse | 10,000,000 | 1.9% | 1.9% |
| Staffan Rasjö | 9,732,083 | 1.8% | 1.8% |
| Originat AB | 7,000,000 | 1.3% | 1.3% |
| Ponderus Invest AB | 5,719,085 | 1.1% | 1.1% |
| Other | 201,180,640 | 37.8% | 37.8% |
| Total | 532,687,650 | 100,0% | 100,0% |